ÂÜÀòÂÒÂ×

Ricarda Finnern has worked in the pharmaceutical industry since 1998. Ricarda began their career as Department Head Pharmaceutical Product Development at RWTH-Aachen and Fraunhofer IME. In 2005, they moved to Dyax s.a. as Director Lead Discovery. Ricarda then joined Bayer Pharma AG in 2008 as Global Program Head. Most recently, Ricarda has been Chief Scientific Officer at LenioBio GmbH since 2019.

Ricarda Finnern obtained a Doctor of Philosophy - PhD in Biotechnology from the University of Cambridge between 1991 and 1995.